Follow-up of a French national cohort of melanoma stage IV and unresectable stage III patients, MelBase.

被引：0
|
作者：
Allayous, Clara
Dalle, Stephane
Saiag, Philippe
Dutriaux, Caroline
Mortier, Laurent
Dupuy, Alain
Lesimple, Thierry
Bahadoran, Philippe
Dalac, Sophie
Marie-Beylot-Barry
Maubec, Eve
Stoebner, Pierre-Emmanuel
Aubin, Francois
Arnault, Jean-Philippe
Verneuil, Laurence
Dreno, Brigitte
Kowal, Anita
Porcher, Raphael
Leccia, Marie Therese
Lebbe, Celeste
机构：
[1] Hop St Louis, Paris, France
[2] Univ Lyon, Canc Res Ctr Lyon, Pierre Benite, France
[3] Hosp Ambroise Pare, Boulogne, France
[4] CHU Bordeaux, Hop St Andre, Bordeaux, France
[5] CHRU Lille, F-59037 Lille, France
[6] CHU Rennes, Ctr Oncodermatol CLCC, Rennes, France
[7] Hop Archet, Nice, France
[8] CHU Dijon Dermatol, Dijon, France
[9] CHU Bordeaux Dermatol, Bordeaux, France
[10] Hop Bichat Claude Bernard, F-75877 Paris, France
[11] CHU Nimes, Dermatol, Nimes, France
[12] CHU Besancon, Dermatol, F-25030 Besancon, France
[13] CHU Amiens Dermatol, Amiens, France
[14] CHU Caen, Dermatol, F-14000 Caen, France
[15] CHU Nantes, Hotel Dieu, F-44035 Nantes 01, France
[16] Univ Paris 07, Informat Hop St Louis Biostat, AP HP, Paris, France
[17] Univ Paris 07, AP HP, Biostat, Paris, France
[18] CHU Grenoble, Dermatol, F-38043 Grenoble, France
[19] Hop St Louis, AP HP, Dept Dermatol, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20113
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Re-evaluation of treatment understanding and quality of life of patients with stage III/IV melanoma after completion of adjuvant therapy or one year of follow-up
    Ziemer, M.
    Fritz, A.
    Friedrich, M.
    Mehnert-Theuerkauf, A.
    Reschke, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 55 - 55
  • [32] Treatment patterns and outcomes for patients with unresectable stage III and metastatic melanoma in the USA
    Tarhini, Ahmad
    Atzinger, Christopher
    Gupte-Singh, Komal
    Johnson, Courtney
    Macahilig, Cynthia
    Rao, Sumati
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (07) : 461 - 473
  • [33] Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients
    S Osella-Abate
    P Savoia
    P Quaglino
    M T Fierro
    C Leporati
    M Ortoncelli
    M G Bernengo
    British Journal of Cancer, 2003, 89 : 1457 - 1462
  • [34] Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients
    Osella-Abate, S
    Savoia, P
    Quaglino, P
    Fierro, MT
    Leporati, C
    Ortoncelli, M
    Bernengo, MG
    BRITISH JOURNAL OF CANCER, 2003, 89 (08) : 1457 - 1462
  • [35] LDH IN THE FOLLOW-UP OF STAGE-I MALIGNANT-MELANOMA
    CAMPORA, E
    REPETTO, L
    GIUNTINI, P
    BERTELLI, G
    AMOROSO, D
    SERTOLI, MR
    ROSSO, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02): : 277 - 278
  • [36] Follow-up for stage 1 teratoma surveillance patients
    Lander, F
    MacBride, S
    Samuel, L
    Howard, G
    Cornbleet, M
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (05) : 900 - 901
  • [37] Phase II randomized, placebo controlled study of sorafenib in combination with dacarbazine in subjects with unresectable Stage III or Stage IV melanoma
    McDermott, D.
    Sosman, J. A.
    Hodi, F. S.
    Gonzalez, R.
    Linette, G.
    Richards, J.
    Jakub, J. K.
    Beeram, M.
    Patel, K.
    Hersch, E.
    EJC SUPPLEMENTS, 2007, 5 (04): : 396 - 396
  • [38] Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience
    Karachaliou, Georgia Sofia
    Ayvali, Fatih
    Collichio, Frances A.
    Lee, Carrie B.
    Ivanova, Anastasia
    Ollila, David W.
    Moschos, Stergios J.
    ONCOLOGY, 2020, 98 (03) : 174 - 178
  • [39] Patterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-up
    Savage, David J.
    Switzer, Benjamin
    Parikh, Rujul
    Song, Jung Min
    Stanek, Carolyn
    Arbesman, Joshua
    Kennedy, Lucy Boyce
    Funchain, Pauline
    MELANOMA MANAGEMENT, 2024, 11 (01)
  • [40] Progression and hyperprogression after anti-PD1 therapy for unresectable stage III or IV melanoma patients.
    Colle, Elise
    Dalle, Stephane
    Mortier, Laurent
    Guillot, Bernard
    Dutriaux, Caroline
    Leccia, Marie Therese
    Dalac, Sophie
    Legoupil, Delphine
    De Quatrebarbes, Julie
    Montaudie, Henri
    Arnault, Jean-Philippe
    Brunet-Possenti, Florence
    Saiag, Philippe
    Momenzadeh, Mathieu
    Dreno, Brigitte
    Porcher, Raphael
    Oriano, Bastien
    Lebbe, Celeste
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345